$5.790
-0.726 (-12.54%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AARD Prediction & Forecast by Similar Chart Analysis
Alphio's AARD stock price prediction model matches the current Aardvark Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.75 (-0.72%). The 1-week path is $5.87 (+1.35%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aardvark Therapeutics, Inc. Stock?
Aardvark Therapeutics is not a good buy right now due to significant operational and financial challenges. The stock is currently priced at $5.79, which is down 56.10% year-to-date and has a troubling RSI of 33.457, indicating it is oversold. Furthermore, the company faces a full clinical hold on its lead drug ARD-101, which has led to a net loss of $14.4 million in Q2 2026, unchanged from the previous year. Analyst ratings have been downgraded, with BofA setting a target of $4, reflecting a lack of confidence in the company's future prospects. The main risk is the ongoing FDA clinical hold, which has already resulted in a 30% drop in stock price following its announcement.
AARD stock price ended at $5.79 on Friday, after losing -12.54%
Aardvark Therapeutics, Inc. (AARD) last closed at $5.79, losing -12.54%. These facts feed the 1-day and 1-week AARD price prediction above.
Forecast Drivers
Aardvark Therapeutics, Inc. (AARD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AARD, ranked by similarity.
Seasonality analysis for AARD
Historically the probability of a positive August return for AARD is 0.00%. January offers the highest probability of a positive month at 90.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AARD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $9.48 | $10.69 | $11.68 | +84.60% |
| Sep 2026 | $11.16 | $11.51 | $13.11 | +98.85% |
| Oct 2026 | $12.68 | $12.93 | $13.14 | +123.29% |
| Nov 2026 | $10.40 | $11.52 | $12.99 | +98.92% |
| Dec 2026 | $10.79 | $11.38 | $11.52 | +96.55% |
In 2026, Aardvark Therapeutics, Inc. (AARD) is projected to range from $9.48 to $13.14.
Aardvark Therapeutics, Inc. 2026 monthly forecast
In Aug 2026, Aardvark Therapeutics, Inc. is projected to average $10.69, with a low of $9.48 and high of $11.68.
In Sep 2026, Aardvark Therapeutics, Inc. is projected to average $11.51, with a low of $11.16 and high of $13.11.
In Oct 2026, Aardvark Therapeutics, Inc. is projected to average $12.93, with a low of $12.68 and high of $13.14.
In Nov 2026, Aardvark Therapeutics, Inc. is projected to average $11.52, with a low of $10.40 and high of $12.99.
In Dec 2026, Aardvark Therapeutics, Inc. is projected to average $11.38, with a low of $10.79 and high of $11.52.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.